ANTİKANSER AKTİVİTE ARAŞTIRMALARINDA ARTEMISIA ANNUA L. BİTKİSİNİN ÖNEMİ

Öz

Amaç: Kanserin dünya çapında ölüm nedenlerinin başında geldiği bilinmektedir. Normal hücre üzerine toksisite göstermeyen, sadece kanser hücresini selektif olarak yok eden ya da gelişimini durduran ilaçları geliştirmek zordur. Daha aktif, daha selektif ve daha az toksik antikanser ilaçlarını geliştirmek kanser araştırmalarının temel hedefleri olmuştur. Artemisia annua L., Geleneksel Çin Tıbbı’nda kullanılan bir tıbbi bitkidir. Bitki, plazmodyum için yoğun olarak araştırılmış ve bu alandaki kullanımı dünya geneline yayılmıştır. Bitkinin aktif bileşenlerinden olan artemisinin, antiviral, antienflamatuar, antiparaziter, antiallerjik, antifibrotik, antiaritmik, immunmodulatör, antitümör ve sitotoksik etkilidir. Bu çalışmanın amacı A. annua bitkisinin aktif maddelerinin ve kanser üzerindeki etkilerinin derlenmesidir.

Anahtar Kelimeler

• antikanser aktivite,Artemisia annua L.,artemisinin,kanser

THE IMPORTANCE OF ARTEMISIA ANNUA L. IN THE ANTICANCER ACTIVITY RESEARCH

Öz

Objective: Cancer is known as one of the main cause of death worldwide. It is difficult to discover novel agents that selectively kill tumor cells or inhibit their proliferation without general toxicity. Searching for more active, more selective and less toxic compounds are the main targets of cancer researches. Artemisia annua L. has been used for a long time as a medicinal plant in Traditional Chinese Medicine (TCM). Artemisinin, which is one of the active compounds of this plant. It has antiviral, antiinflammatory, antiparasitic, antiallergic, antifibrotic, antiarrhythmic, immunmodulator, antitumorigenic, cytotoxic properties. The aim of this study is to review the A. annua compounds and s

earch for their effects against various cancer cell lines.

Anahtar Kelimeler

• anticancer activity,Artemisia annua L.,artemisinin,cancer

Kaynakça

1. 1. Giordano, S., Petrelli, A. (2008). From single-to multi-target drugs in cancer therapy: when a specificity becomes an advantage. Current Medicinal Chemistry, 15(5), 422-32. 2. Liersch, R., Soicke, H., Stehr, C., Tullner, HU. (1986). Formation of artemisinin in Artemisia annua during one vegetation period. Planta Medica, 52, 387–390. 3. Simonnet, X., Quennoz, M., Carlen, C. (2006). "New Artemisia annua hybrids with high artemisinin content". XXVII International Horticultural Congress-IHC2006: International Symposium on Asian Plants with Unique Horticultural, 769, 371–373. 4. Miller, L.H., Su, X. (2011) Artemisinin: Discovery from the Chinese Herbal Garden Cell, 146(6), 855–858. 5. Li, Y. (2012) Qinghaosu (artemisinin): Chemistry and pharmacology. Acta Pharmacologica Sinica, 33(9), 1141–1146. 6. Efferth, T., Dunstan, H., Sauerbrey, A., Miyachi, H., Chitambar, C.R. (2001) The anti-malarial artesunate is also active against cancer. International Journal of Oncology, 18(4), 767-73. 7. Ng, D.S., Liao, W., Tan, W.S., Chan, T.K., Loh, X.Y., Wong, W.S. (2014). Anti-malarial drug artesunate protects against cigarette smoke-induced lung injury in mice. Phytomedicine, 21(12), 1638-44. 8. O'Neill, P.M., Barton, V.E., Ward, S.A. (2010). The molecular mechanism of action of artemisinin - the debate continues. Molecules, 15(3), 1705-21. 9. Haynes, R.K., Cheu, K.W., N'Da, D., Coghi, P., Monti, D. (2013). Considerations on the mechanism of action of artemisinin antimalarials: part 1-the 'carbon radical' and 'heme' hypotheses. Infectious Disorders - Drug Targets, 13(4), 217-77. 10. Antoine, T., Fischer, N., Amewu, R., M.O’Neil, P., Ward, S.A., Biagini, G.A. (2014). Rapid kill of malaria parasites by artemisinin and semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potential. Journal of Antimicrobial Chemotherapy, 69, 1005–1016. 11. Mercer, A.E., Maggs, J.L., Sun, X.M., Cohen, G.M., Chadwick, J., O'Neill, P.M., Park, B.K. (2007). Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds. Journal of Biological Chemistry, 30;282 (13) 9372-82. 12. Torti, S.V., Torti, F.M. (2013). Iron and cancer: more ore to be mined Nature Reviews Cancer, 13(5), 342–355. 13. Knekt, P., Reunanen, A., Takkunen, H., Aromaa, A., Heliövaara, M., Hakulinen, T. (1994). Body iron stores and risk of cancer. International Journal of Cancer, 56(3), 379-82. 14. Hann, H.W., Stahlhut, M.W., Blumberg, B.S. (1988). Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. Cancer Research, 48(15), 4168-70. 15. Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun.X., Kang, R., Tang, D. (2016). Ferroptosis: process and function. Cell Death Differantion, 23(3), 369–379. 16. Kwok, J.C., Richardson, D.R. (2002). The iron metabolism of neoplastic cells: alterations that facilitate proliferation? Critical Reviews in Oncology/Hematology, 42(1), 65-78. 17. Zhang, S., Gerhard, G.S. (2009). Heme Mediates Cytotoxicity from Artemisinin and Serves as a General Anti-Proliferation Target. Plos One, 4(10), e7472. 18. Crespo-Ortiz, M.P., Wei, M.Q. (2012). Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. Journal of Biomedicine and Biotechnology, Volume 2012, Article ID 247597. 19. Meshnick, S.R., Thomas, A., Ranz, A., Xu, C.M., Pan, H.Z. (1991). Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. Molecular and Biochemical Parasitology, 49(2), 181-189. 20. Lai, H.I., Sasaki, T., Singh, N.P. (2005). Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds. Expert Opinion on Therapeutic Targets, 9(5), 995-1007. 21. Meunier, B., Robert, A. (2010). Heme as trigger and target for trioxane-containing antimalarial drugs. Accounts of Chemical Research, 43(11),1444-1451. 22. Yang, W.S., Stockwell, B.R. (2016). Ferroptosis: Death by Lipid Peroxidation. Trends in Cell Biology, 26(3), 165-176. 23. Hevia, A.O., Fernández de Mattos, S., Villalonga, P., Rodriquez, J. (2009). Molecular biology of mantle cell lymphoma: From profiling studies to newtherapeutic strategies. Blood Reviews 23, 205–216. 24. Nakase, I., Lai, H., Singh, N.P., Sasaki, T. (2008). Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. International Journal of Pharmaceutics, 354(1-2), 28-33. 25. Gharib, A., Faezizadeh, Z., Ali Reza, S., Namin, M., Saravani, R. (2015). Experimental treatment of breast cancer-bearing BALB/c mice by artemisinin and transferrin-loaded magnetic nanoliposomes. Pharmacognosy Magazine (Suppl S1), 117-122. 26. Michaelsen, F.W., Saeed, M.E., Schwarzkopf, J., Efferth, T. (2015). Activity of Artemisia annua and artemisinin derivatives, in prostate carcinoma. Phytomedicine, 22(14), 1223-1231. 27. Jeong, D.E., Song, H.J., Lim, S., Lee, S.J., Lim, J.E., Nam, D.H., Joo, K.M., Jeong, B.C., Jeon, S.S., Choi, H.Y., Lee, H.W. (2015). Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis. Oncotarget, 6, 33046-33064. 28. Du, J.H., Zhang, H.D., Ma, Z.J., Ji, K.M. (2010). Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. Cancer Chemotherapy and Pharmacology, 65(5), 895-902. 29. Zhou, X., Sun, W.J., Wang, W.M., Chen, K., Zheng, J.H., Lu, M.D., Li, P.H., Zheng, Z.Q. (2013). Artesunate inhibits the growth of gastric cancer cells through the mechanism of promoting oncosis both in vitro and in vivo. Anticancer Drugs, 24(9), 920-927. 30. Kast, R.E., Karpel-Massler, G., Halatsch, M.E (2014). CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide. Oncotarget, 5, 8052-8082. 31. Wang, Q., Wu, L.M., Li, A.Y., Zhao, Y., Wang, N.P. (2001). Experimental studies of antitumor effect of artesunate on liver cancer. Zhongguo Zhong Yao Za Zhi, 26(10), 707-708, 720(Çince). PMID: 12776323. 32. Breuer, E., Efferth, T., (2014). Treatment of Iron-Loaded Veterinary Sarcoma by Artemisia. Natural Products and Bioprospecting, 4(2), 113-8. 33. Krishna, S., Ganapathi, S., Ster, I.C., Saeed, M.E., Cowan, M., Finlayson, C., Kovacsevics, H., Jansen, H., Kremsner, P.G., Efferth, T., Kumar, D. (2015). A Randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer. EBioMedicine, 2(1), 82-90. 34. Tran, K.Q., Tin, A.S., Firestone, G.L. (2014). Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling. Anticancer Drugs, 25(3), 270-81. 35. Yamachika, E., Habte, T., Oda, D. (2004). Artemisinin: an alternative treatment for oral squamous cell carcinoma. Anticancer Research, 24(4), 2153-2160. 36. Berger, T.G., Dieckmann, D., Efferth, T., Schultz, E.S., Funk, J.O., Baur, A., Schuler, G. (2005). Artesunate in the treatment of metastatic uveal melanoma--first experiences. Oncology Reports, 14(6), 1599-1603. 37. Mu, D., Chen, W., Yu, B., Journal of Cancer Research and Clinical OncologyZhang, C., Zhang, Y., Qi, H. (2007). Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells. Methods and Findings in Experimental and Clinical Pharmacology, 29(1), 33-8.